Used primarily in the treatment of severe chronic obstructive pulmonary disease (COPD), this compound helps reduce airway inflammation and prevent disease exacerbations. It acts as a selective inhibitor of phosphodiesterase-4, which increases cyclic AMP levels in inflammatory cells, leading to decreased release of pro-inflammatory mediators. It is particularly beneficial in patients with chronic bronchitis and a history of frequent flare-ups. The compound is administered orally and has shown efficacy in improving lung function and health-related quality of life. It may also have potential in treating other inflammatory conditions such as asthma, psoriasis, and atopic dermatitis, though these uses are less established.